Stop Wasting AI on Personal Productivity: 60% of Leaders Pivot to Agentic Automation for Real Enterprise Value
New Research Confirms Costly Copilot Limitations, Driving Demand for Governed, Process-Centric AI…
PIF launches new company to deliver Expo 2030 Riyadh
Expo 2030 Riyadh Company will develop Expo as a model for sustainable…
Expro Wins Well Test Contract for Major UK CCS Project
Latest contract extends Expro’s decade-plus support of the UK Carbon Capture and…
Interlace Launches White-Label Card Solutions to Power Personalized Enterprise Payments
SINGAPORE, June 16, 2025 /PRNewswire/ -- As digital transformation accelerates, enterprises are…
Desay Battery Unveils Innovative Energy Storage Solutions at SNEC PV+ Expo, Announces Strategic Partnership with Turkish Energy Leader Demir Enerji
HUIZHOU, China, June 12, 2025 /PRNewswire/ -- Desay Battery, a global leader…
National Science Teaching Association Welcomes New Board and Leadership Council Members
MCLEAN, Va.--(BUSINESS WIRE)--#NSTA--The National Science Teaching Association (NSTA) today announced the newest…
Ellavoz Impact Capital Celebrates Cedar Creek Estates with Site Dedication in Jacksonville, Florida
Vertical Construction is Well UnderwayJACKSONVILLE, Fla.--(BUSINESS WIRE)--Ellavoz Impact Capital (EIC), a leading…
Kia Announces May 2025 Global Sales Results
May 2025 global sales of 269,148 units, up 1.7% Y/yOutside of Korea,…
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor,…